Greenway loses $134,975 in fiscal Q3

Executive Summary

• Greenway Greenhouse Cannabis Corp. released its unaudited interim financial statements for the three and nine months ended December 31, 2025, reporting significant revenue growth and margin expansion.
• The company achieved a 40% year-over-year increase in net cannabis revenue for Q3, reaching $2.35 million, while improving gross margins to 29% and generating positive adjusted EBITDA for the fifth consecutive quarter.
• The release also details the issuance of common shares to a corporate finance consultant to settle outstanding fees, subject to a standard hold period.

Key Details

• Q3 Revenue Performance: Net cannabis revenue for the quarter ended Dec. 31, 2025, was $2,348,797, an increase of $672,076 (40%) compared to fiscal Q3 2025 ($1,676,721).
• Sales Price: Average net sales price per gram was $1.51 (down from $1.58 in fiscal Q3 2025).
• Nine-Month Revenue: Net cannabis revenue for the nine months ended Dec. 31, 2025, increased to $6,062,528 (compared to $5,877,837 in the prior year period).
• Cost Efficiency: Cash cost per gram sold decreased to 92 cents, down from $1.03 in fiscal Q3 2025 (a reduction of over 10%).
• Gross Profit & Margin: Gross profit improved to $680,589 in Q3 (up from $249,197 in fiscal Q3 2025). Gross margin expanded to 29% (up from 15%). For the nine-month period, gross profit totaled $2,321,996, representing a >350% increase year-over-year.
• Operating Income: The company generated positive operating income for the fourth consecutive quarter.
• Adjusted EBITDA: Adjusted EBITDA was $399,738 in Q3 (up from $85,758 in fiscal Q3 2025), marking the fifth consecutive quarter of positive adjusted EBITDA.
• Inventory: Finished goods inventory totaled 3,053,665 grams, valued at $3,377,433.
• Liquidity: Cash on hand was $1,181,770 at quarter-end. Working capital (excluding amounts due to related parties) was $5,819,285.
• Share Issuance: The company issued 402,549 common shares to Abingdon Capital Corp. (an arm's-length consultant) to satisfy a portion of monthly work fees owed for corporate-finance advisory services.
• Share Pricing & Terms: Shares were issued at deemed prices between 15 cents and 25 cents per share. All shares are subject to a hold period of four months and one day from the date of issuance.

Notable Quotes

• Jamie D'Alimonte, CEO: "We are pleased to report our Q3 results which delivered revenue growth of 40 per cent year over year, expanding margins and our fifth consecutive quarter of positive adjusted EBITDA... Our results reflect a business that is gaining scale, improving unit economics and strengthening strategic customer relationships."
• Carl Mastronardi, President: "Our production team was able to reduce cash cost per gram over 10 per cent, to 92 cents, from $1.03 a year ago. We are demonstrating that disciplined execution in this market drives durable results."